Korro Bio (KRRO) Free Cash Flow (2018 - 2026)

Korro Bio's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$16.1 million for Q1 2026.

• Quarterly Free Cash Flow rose 34.5% year-over-year to -$16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70.6 million (up 5.92% YoY) and the FY2025 annual result came in at -$79.1 million, down 1.41% from the prior year.
• Free Cash Flow was -$16.1 million for Q1 2026 at Korro Bio, up from -$17.8 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$8.9 million in Q4 2024 and bottomed at -$27.5 million in Q1 2024.
• A 5-year average of -$18.1 million and a median of -$17.8 million in 2025 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2024 — Free Cash Flow jumped 60.69% — and 2025, when it plunged 98.79%.
• Korro Bio's Free Cash Flow stood at -$16.2 million in 2022, then sank by 40.83% to -$22.8 million in 2023, then soared by 60.69% to -$8.9 million in 2024, then plunged by 98.79% to -$17.8 million in 2025, then climbed by 9.51% to -$16.1 million in 2026.
• Business Quant data shows KRRO's Free Cash Flow at -$16.1 million in Q1 2026, -$17.8 million in Q4 2025, and -$17.4 million in Q3 2025.